Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ ÀǾàǰÁ¤Ã¥¿¬ "¿Â¶óÀÎ ¿¬¼ö±³À°¿¡ CPD µµÀÔÇØ¾ß"
³»   ¿ë
¹Ì±¹¡¤¿µ±¹¡¤È£ÁÖ CPD°³³ä Àû¿ë...ÀÚ±âÁÖµµ ÇнÀ °¡´É


[µ¥Àϸ®ÆÊ=±è¹Î°Ç ±âÀÚ] ¾à»ç ¿Â¶óÀÎ ¿¬¼ö±³À°¿¡ ÇØ¿Ü ¾à»ç±³À°(Continuing Professional Development, CPD) °³³äÀ» µµÀÔÇØ¾ß ÇÑ´Ù´Â ÁÖÀåÀÌ ³ª¿Ô´Ù.

ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò(¼ÒÀå ¹ÚÇý°æ)´Â 9ÀÏ ¿Ã ÇÑ ÇØ ¾à»çµé¿¡°Ô ¾çÁúÀÇ ±³À°Á¦°øÀ» À§ÇÑ ¿Â¶óÀÎ ¿¬¼ö±³À°¼¾ÅÍ ¿î¿µ ¹ßÀü ¹æÇâ ¿¬±¸¸¦ ÁøÇàÇß´Ù°í ¹àÇû´Ù.

ÃÖ±Ù ´ëÇѾà»çȸ´Â ¾à»ç ¿¬¼ö±³À°À» °³ÆíÇÏ°í »çÀ̹ö¿¬¼ö¿øÀ» ±¸ÃàÇß´Ù. ÇÏÁö¸¸ ¸¹Àº ¼±Áø±¹ÀÌ 20³â ÀüºÎÅÍ Áö¼ÓÀûÀ̸ç ü°èÀûÀÎ ¾à»ç¿¬¼ö±³À° °³¹ßÀ» À§ÇÑ CPD(Continuing Professional Development) °³³äÀ» Àû¿ëÇØ ¿Â °Í°ú ´Þ¸® ±¹³»¿¡¼­´Â ¾à´ë 6³âÁ¦ Á¹¾÷ ÈÄ CPD °³³äÀº ã¾Æº¼ ¼ö ¾ø´Ù´Â Á¤Ã¥¿¬±¸¼Ò ¿¬±¸ °á°ú´Ù.

CPD´Â Àü¹®°¡µéÀÌ ½Ç¹«¿¡¼­ ÀÚ½ÅÀÇ Àü¹®¼ºÀ» À¯ÁöÇϰųª ÁõÁøÇÒ ¼ö ÀÖµµ·Ï ÀÚ±â ÁÖµµÀûÀÎ Æò»ý ÇнÀÀ» ÁõÁøÇÏ´Â °³³äÀÌ´Ù. °³°³ÀÎ Àü¹®°¡´Â °¢ÀÚ ¹è¿ò¿¡ ´ëÇÑ Ã¥ÀÓÀ» Áö°í ¹Ý¿µ(Reflection), °èȹ(Planning), ÇнÀ(Learn), Æò°¡(Evaluation), ±×¸®°í Àû¿ë(Application)ÀÇ ´Ü°è(CPD Cycle)¸¦ µû¸¦ °ÍÀ» ¿ä±¸¹Þ´Â´Ù.

 ¡ã Mycpd Àû¿ë °³³ä

Á¤Ã¥¿¬±¸¼Ò´Â "À̰°Àº CPD ¼øÈ¯(Cycle)À» Àû¿ëÇØ ü°èÀûÀÎ ¿¬¼ö±³À°À» ¼öÇàÇÒ ¼ö ÀÖµµ·Ï '¹Ì±¹ ¾àÇб³À°Æò°¡¿ø(Accreditation Council for Pharmaceutical Education, ACPE)'Àº ¾à»çµé¿¡°Ô º»ÀÎ ÇнÀ °èȹ°ú Ȱµ¿ ¿Ï·á ¿©ºÎ¸¦ È®ÀÎÇϰí ÀÖ´Ù"°í ¼³¸íÇß´Ù.

±×·¯¸é¼­ Á¤Ã¥¿¬±¸¼Ò´Â "ÇнÀ ÃæÁ·µµ¿Í ÇѰèÁ¡À» ÆÄ¾ÇÇÏ°í ³ª¾Æ°¡ »õ·Î¿î ÇнÀ¿µ¿ª Æò°¡¿Í ¹Ý¿µ, ½Ç¹« º¯È­ µî °á°ú¸¦ ±â·ÏÇϵµ·Ï Çϰí ÀÖ´Ù"¸ç "ÇнÀ ÁøÇà ´Ü°èº°·Î º»ÀÎÀÇ ¿¬¼ö±³À° À̼ö ÇöȲÀ» °èȹÇϰí Á¡°ËÇÒ ¼ö ÀÖ´Â Ç÷§ÆûÀÎ MyCPD¸¦ ¿î¿µ Çϰí ÀÖ´Ù"°í °­Á¶Çß´Ù.

Á¤Ã¥¿¬±¸¼Ò´Â È£ÁÖ ¾à»ç ±æµå¿¡¼­´Â ½Ç¹« ¹üÀ§ÀÇ Á¤ÀÇ, ÇнÀ Çʿ伺 Á¤ÀÇ, °èȹ Á¡°Ë, ±×¸®°í ¼ö¸³µÈ °èȹ¿¡ µû¶ó ÃßõµÈ ±³À° ÇÁ·Î±×·¥ Áß ¿øÇÏ´Â ÇÁ·Î±×·¥À» ¼±ÅÃÇÏ´Â °úÁ¤À» À¥ÆäÀÌÁö¸¦ Á¦°øÇÑ´Ù°í »ç·Ê¸¦ µé¾ú´Ù.

Á¤Ã¥¿¬±¸¼Ò´Â "º»ÀÎÀÌ ½Ç¹«¿¡¼­ ºÎÁ·ÇÏ´Ù°í ´À³¤ ºÎºÐÀ̳ª °­È­ÇÏ°í ½ÍÀº ºÎºÐ µîÀ» ¹Ý¿µÇØ ÀÛ¼ºÇÏ´Â ÀÚ±âÁÖµµ ÇнÀ °èȹ¼­ ÀÛ¼º ÀÚü°¡ ÇнÀÀÚ¿¡°Ô µ¿±â ºÎ¿©¿Í ü°èÀûÀÎ ÇнÀ ½ÃÀÛ¿¡ Å« µµ¿òÀ» ÁÖ´Â °ÍÀ¸·Î º»´Ù"°í ¼³¸íÇß´Ù.

È£ÁÖ¾à»çȸ´Â ÃÑ 309°³ÀÇ ¿¬¼ö±³À° °­Á¸¦ ¿Â¶óÀÎÀ¸·Î Á¦°øÇϰí ÀÖ´Ù. ¿µ±¹ÀÇ ÇÑ ¿Â¶óÀο¬¼ö±³À° ±â°üÀÎ CPPE(Centre for Pharmacy Postgraduate Education)´Â 260°³ °­ÀǸ¦ ¿Â¶óÀÎÀ¸·Î Á¦°øÇϰí ÀÖ´Ù.

ÀÌ¿¡ ¹ÝÇØ ±¹³» »çÀ̹ö¿¬¼ö¿øÀº ¾à»çÁ¦µµ, ¾à±¹°ü¸® ¹× °æ¿µ, ÀÓ»ó(1), ÀÓ»ó(2) Ç׸ñº°·Î ÃÑ 16°³ °­ÀǸ¦ Á¦°øÇϰí ÀÖ¾î ±³À° ³»¿ë È®´ë Ãø¸é¿¡¼­´Â Á¡ÁøÀû °­È­¸¦ ±â´ëÇÒ ¼ö ÀÖ´Ù´Â Á¤Ã¥¿¬±¸¼Ò ºÐ¼®ÀÌ´Ù.

¿µ±¹¾à»çÀ§¿øÈ¸(General Pharmaceutical Council, GPhC)´Â °³ÀΰèÁ¤À» ÅëÇØ ÇнÀÀÚ ½º½º·Î ¾à±¹ Àü¹®°¡·Î¼­ Ç¥Áؾ÷¹« Áöħ¿¡ ¸ÂÃç Á÷´É ¼öÇØ¿¨ ¿ä±¸µÇ´Â ±âÁØÀ» 1°³ ÀÌ»ó ÃæÁ·½ÃÄ×´ÂÁö Æò°¡¸¦ ¿Ï·áÇÑ ÈÄ, ÆòÁ¡À» ÀÎÁ¤¹Þ´Â 'ÀÚ±â¹Ý¿µ(Reflective Account)' ¹æ½ÄÀ» Çϰí ÀÖ´Ù. ¾à»ç°¡ ÀÚ½ÅÀÇ ¾à·á¼­ºñ½º°¡ ȯÀÚ¿¡°Ô ½ÇÁ¦·Î ¾î¶² ¿µÇâÀ» ¹ÌÃÆ´ÂÁö Àß ÆÄ¾ÇÇÒ ¼ö ÀÖ°Ô µµ¿ÍÁØ´Ù.

ÀÌ¿¡ Á¤Ã¥¿¬±¸¼Ò´Â "¾à»ç¿¬¼ö±³À° ¿Â¶óÀμ¾ÅÍ È°¿ë°ú Æò°¡ ¹æ¾È ¿¬±¸¸¦ ÅëÇØ Àü¹ÝÀûÀÎ ¿¬¼ö±³À° °­ÀÇ ¸¸Á·µµ »Ó¸¸ ¾Æ´Ï¶ó ÇнÀµ¿±â, ±³À° ¸Å°³Ã¼ µî °°Àº ¿µ¿ªÀ» Æ÷ÇÔÇÑ Àü ¿µ¿ª¿¡ °ÉÄ£ Àü¹ÝÀûÀÎ Æò°¡°¡ °¡´ÉÇÑ ¸ðµ¨°ú ¹®Ç×À» °³¹ßÇß´Ù"¸ç "¿¬±¸¼Ò ȨÆäÀÌÁö¸¦ ÅëÇØ °ø°³ÇÒ ¿¹Á¤"À̶ó°í °­Á¶Çß´Ù.

¹ÚÇý°æ ¼ÒÀåÀº "¿Â¶óÀÎ ±³À°Àº ´ÜÁ¡µµ ÀÖÁö¸¸, ½Ã°ø°£¿¡ Á¦¾àÀÌ ¾ø°í ¿©·¯ µðÁöÅÐ ±â¼úÀ» Ȱ¿ëÇÒ ¼ö ÀÖ´Ù´Â ºÐ¸íÇÑ ÀåÁ¡µµ Á¸ÀçÇÑ´Ù"¸ç "µðÁöÅÐ ±â¼úÀ» Ȱ¿ëÇØ ¾Õ¼­ Á¦½ÃÇÑ ¹æ½ÄÀ» ¹Ý¿µÇÑ CPD¸¦ »çÀ̹ö¿¬¼ö¿ø¿¡ Àû¿ëÇÒ ¼ö ÀÖ´Ù¸é ¿Â¶óÀÎ ¿¬¼ö±³À° ÀåÁ¡À» º¸´Ù ´õ ±Ø´ëÈ­ÇÒ ¼ö ÀÖÀ» °Í"¶ó°í ÁÖÀåÇß´Ù.
±è¹Î°Ç ±âÀÚ (kmg@dailypharm.com)
±â»ç Ãâó : http://www.dailypharm.com/Users/News/NewsView.html?ID=271333&REFERER=NP


 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
92 [¸ÞµðÆÄ³ª´º½º]'Äڷγª19 ´ëÀÀ¡¤ÅëÇÕµ¹º½' ´Ù·é ÀǾàǰÁ¤Ã¥¿¬±¸ ¹ß°£  ±è¼±Èñ 2021-01-19 6
91 [¾à»ç°ø·Ð] ¾à±¹ °ÅÁ¡ Àڻ쿹¹æ»ç¾÷, »ý¸íÁöÅ´ÀÌ ¿ªÇÒ 'ÅåÅå'  ±è¼±Èñ 2021-01-19 6
90 [µ¥Àϸ®ÆÊ] ÀϺ»¾à±¹ÀÇ ÁøÈ­¡¦Ä«µå·Î 'Áߺ¹Åõ¾à¡¤³²Àº ¾à °ü¸®±îÁö'  ±è¼±Èñ 2021-01-19 9
89 [´ëÇѾà»çÀú³Î] ¼¼ÀÌÇÁ¾à±¹¡¤¹æ¹®¾à·á µî Ȱµ¿ Áö¼Ó Áõ°¡ ÀÌÁö¿¬ 2021-01-19 4
88 [´ëÇѾà»çÀú³Î] ¾à±¹ ó¹æÁýÁßµµ º¯È­¿Í ¾à±¹¾à»çÀÇ »çȸÀû ¿ªÇÒ Ãß±¸ ÀÌÁö¿¬ 2021-01-13 49
87 [´ëÇѾà»çÀú³Î] ÀåÁ¡Àº Ű¿ì°í ´ÜÁ¡Àº ¾ø¾Ö´Â ±³À°¹æ¹ýÀº? ÀÌÁö¿¬ 2021-01-06 84
86 [´ëÇѾà»çÀú³Î] 'Àڱ⠹ݿµ ¾ç½Ä' ÅëÇØ ¾à±¹ Àü¹®°¡ ±âÁØ ÆÄ¾Ç ÀÌÁö¿¬ 2020-12-29 83
85 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-22 94
84 ¹Ì±¹¡¤¿µ±¹ ¾à»ç, ¿Â¶óÀÎÀ¸·Î ¾î¶»°Ô °øºÎÇϳª ±è¼±Èñ 2020-12-16 96
83 ÀǾàǰÁ¤Ã¥¿¬ "¿Â¶óÀÎ ¿¬¼ö±³À°¿¡ CPD µµÀÔÇØ¾ß" ±è¼±Èñ 2020-12-16 94
82 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-16 81
81 [´ëÇѾà»çÀú³Î] Áö¿ª ¿©°Ç ¸ÂÃá 'Ä¡¸Å¾È½É¸¶À»'+'Ä¡¸Å¾È½É¾à±¹' ¿î¿µ ÀÌÁö¿¬ 2020-12-08 101
80 [´ëÇѾà»çÀú³Î] È£ÁÖ ¾à±¹ÀÇ Ä¡¸Å Äɾî Àü·«Àº? ÀÌÁö¿¬ 2020-12-01 112
79 [¾à»ç°ø·Ð] Ä¡¸Å±¹°¡Ã¥ÀÓÁ¦ '¿Ö ¾à»ç´Â ºüÁ³À»±î'¡¦¿Ü±¹Àº ¾î¶»°Ô? ±è¼±Èñ 2020-11-25 131
78 [µ¥Àϸ®ÆÊ] ³â µÚ Ä¡¸ÅÀα¸ 100¸¸ ½Ã´ë¡¦¾à±¹ ¿ªÇÒÀ» ã¾Æ¶ó ±è¼±Èñ 2020-11-25 131

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»